NCT01657929 - H5-VLP + GLA-AF Vaccine Trial in Healthy Adult Volunteers | Biotech Hunter

Enrollment

105

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Influenza A Subtype H5N1 Infection

Interventions

BIOLOGICAL

H5-VLP + GLA-AF

H5-VLP antigen and GLA-AF adjuvant. 2 injections at Days 0, and 21.

BIOLOGICAL

H5-VLP alone

H5-VLP antigen alone. 2 injections at Days 0, and 21.

BIOLOGICAL

H5-VLP + Alhydrogel(R)

H5-VLP antigen and Alhydrogel(R) adjuvant. 2 injections at Days 0, and 21.

BIOLOGICAL

Licensed H5N1 vaccine

Licensed H5N1 vaccine. 2 injections given on Days 0 and 21.

Trial Locations (3)

Covance, Inc., Daytona Beach

Covance, Inc., Madison

Covance, Inc., Dallas